In this week’s episode, we explore the expanding role of SARMs in the performance-enhancing drug landscape. Often marketed in “research-only” products, these compounds are anything but risk-free. We delve into a recent systematic review outlining their adverse effects and take a closer look at a compelling case study of drug-induced liver injury and rhabdomyolysis linked to SARM use. Tune in as we unpack the toxicological truths behind these so-called “safer” anabolic alternatives.

Hope you enjoy!

Links to papers we discussed:

https://pmc.ncbi.nlm.nih.gov/articles/PMC10204391/

https://pmc.ncbi.nlm.nih.gov/articles/PMC8538264/

https://academic.oup.com/smoa/article/12/2/qfae018/7636151

Disclaimer: All opinions are our own.

Find us on instagram: @the_tox_lab

Email us here: [email protected]